Search filters

List of works by Stéphane Epelbaum

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

scientific article

Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.

scientific article published on 9 January 2018

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD

scientific article published on 14 October 2020

Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study

scientific article published on 18 July 2017

Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease

scientific article published on 17 May 2017

Free and Cued Selective Reminding Test - accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: A large-scale biomarker-characterized monocenter cohort study (ClinAD).

scientific article published on 18 February 2017

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years

scientific article published on 24 June 2019

Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.

scientific article

Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept

scientific article published on 7 February 2017

Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease

scientific article